Nicholas W. Baxter - 15 May 2025 Form 4 Insider Report for Lexaria Bioscience Corp. (LEXX)

Source evidence Original filing metadata and source links for verification. 4 source fields
SEC form
4
Accepted by SEC
16 May 2025, 16:40:21 UTC
Prior SEC filing
30 Jul 2024
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/Nicholas Baxter/

Key filing fact

Nicholas W. Baxter filed Form 4 for Lexaria Bioscience Corp. (LEXX) on 16 May 2025.

Key facts

  • This page summarizes Nicholas W. Baxter's Form 4 filing for Lexaria Bioscience Corp. (LEXX).
  • 1 reported transaction and 9 derivative rows are listed below.
  • Accepted by SEC: 16 May 2025, 16:40.

Change

  • Previous filing in this sequence was filed on 30 Jul 2024.
  • Current net transaction value: $0.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reporting Owners (1)

CIK 0001312326 Primary reporting owner

Baxter Nicholas W

Relationship
Director
Address
37H KING'S GATE, ABERDEEN, ABERDEENSHIRE, SCOTLAND, UNITED KINGDOM
Signature
/Nicholas Baxter/
Signature date
16 May 2025

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

LEXX holding

common shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,000
Date
15 May 2025
Ownership
Direct

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

LEXX transaction Derivative

Stock Options

Award

Transaction value
$0
Shares
+11,000
Change %
+21%
Price
$0.000000
Shares after
63,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
11,000
Exercise price
$1.04
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,500
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
1,500
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
6,500
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
5,000
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,400
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
1,900
Exercise price
$3.00
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
11,800
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
3,400
Exercise price
$3.39
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
30,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
18,200
Exercise price
$1.96
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
35,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
5,000
Exercise price
$0.8700
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
40,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
5,000
Exercise price
$2.36
LEXX holding Derivative

Stock Options

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
52,000
Date
15 May 2025
Ownership
Direct
Underlying class
Common Shares
Underlying amount
12,000
Exercise price
$3.39
* marks a reported price that did not pass the local price check.
We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .